EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Eliminating first trimester combined testing: Consequences for early detection of significant fetal anomalies

M A Lugthart iD, H Heinrich iD, I Ertugrul, E N Nsiah-Asare, K van de Kamp, I H Linskens, M C van Maarle, E van Leeuwen, E Pajkrt

Prenatal Diagnosis · 2024

DOI: 10.1002/pd.6552 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Prenatal Diagnosis, 2024. Verfasst von M A Lugthart und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Pregnancy Trimester, First, Cell-Free Nucleic Acids. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective To determine whether implementation of cell‐free DNA (cfDNA) testing for aneuploidy as a first‐tier test and subsequent abolition of first trimester combined testing (FCT) affected the first trimester detection (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pregnancy Trimester, FirstCell-Free Nucleic AcidsHumansFemalePregnancyAdultCohort StudiesCongenital AbnormalitiesAneuploidyPrenatal DiagnosisEarly Diagnosis

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.
  • Amsterdam Reproduction and Development, Amsterdam, The Netherlands.
  • Department of Obstetrics and Gynecology, Amsterdam UMC Location Vrije Universiteit, Amsterdam, The Netherlands.
  • Department of Clinical Genetics, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.

ORCID-Profile: M A Lugthart, H Heinrich

Zitieren

APA

Lugthart, M. A., Heinrich, H., Ertugrul, I., Nsiah-Asare, E. N., van de Kamp, K., Linskens, I. H., van Maarle, M. C., van Leeuwen, E., & Pajkrt, E. (2024). Eliminating first trimester combined testing: Consequences for early detection of significant fetal anomalies. Prenatal Diagnosis. https://doi.org/10.1002/pd.6552

Vancouver

Lugthart MA, Heinrich H, Ertugrul I, Nsiah-Asare EN, van de Kamp K, Linskens IH, et al. Eliminating first trimester combined testing: Consequences for early detection of significant fetal anomalies. Prenatal Diagnosis. 2024. doi:10.1002/pd.6552

BibTeX
@article{Lugthart2024,
  author = {Lugthart, M A and Heinrich, H and Ertugrul, I and Nsiah-Asare, E N and van de Kamp, K and Linskens, I H and van Maarle, M C and van Leeuwen, E and Pajkrt, E},
  title = {Eliminating first trimester combined testing: Consequences for early detection of significant fetal anomalies},
  journal = {Prenatal Diagnosis},
  year = {2024},
  doi = {10.1002/pd.6552}
}
Kostenlos starten →